Some studies have reported that FN1 stimulates the growth of human cancer cells by binding to the α5β1 integrin receptor on the cell surface and activating MEK1/ERK pathway[26–29] suggests that activation of this pathway is associated with tumor development. The gene discussed is MAP2K1; the disease is neoplasm.